CONSOLIDATED BALANCE SHEETS - USD ($) $ in Thousands	Mar. 31, 2017	Dec. 31, 2016
Current Assets:
Cash and cash equivalents (restricted balances of $81,776 and $73,272 at December 31, 2016 and March 31, 2017, respectively)	$ 273,587	$ 304,508
Accounts receivable, less allowance for doubtful accounts of $5,644 and $6,171 at December 31, 2016 and March 31, 2017, respectively	634,102	606,764
Short-term investments (restricted balances of $227,795 and $220,284 at December 31, 2016 and March 31, 2017, respectively)	306,549	297,493
Pharmaceutical inventory	62,374	58,995
Other current assets (restricted balances of $38,785 and $34,002 at December 31, 2016 and March 31, 2017, respectively)	52,717	51,507
Total Current Assets	1,329,329	1,319,267
Property and equipment, net	166,536	172,524
Long-term investments (restricted balances of $6,306 and $5,699 at December 31, 2016 and March 31, 2017, respectively)	7,151	7,760
Deferred income taxes	4,507	3,125
Other long-term assets	15,709	12,725
Goodwill	742,775	742,054
Other intangible assets, net	177,054	186,232
Total Assets	2,443,061	2,443,687
Current Liabilities:
Accounts payable	82,385	95,635
Accrued liabilities	165,632	202,176
Short-term contingent consideration	9,761	9,354
Medical claims payable	174,302	184,136
Other medical liabilities	202,533	197,856
Current debt and capital lease obligations	428,795	403,693
Total Current Liabilities	1,063,408	1,092,850
Long-term debt and capital lease obligations	207,549	214,686
Tax contingencies	14,764	13,981
Long-term contingent consideration	1,343	1,799
Deferred credits and other long-term liabilities	20,032	15,882
Total Liabilities	1,307,096	1,339,198
Redeemable non-controlling interest	4,492	4,770
STOCKHOLDERS' EQUITY
Preferred stock, par value $.01 per share Authorized—10,000 shares at December 31, 2016 and March 31, 2017-Issued and outstanding-none
Other Stockholders' Equity:
Additional paid-in capital	1,200,309	1,186,283
Retained earnings	1,307,035	1,289,288
Accumulated other comprehensive loss	(196)	(175)
Ordinary common stock in treasury, at cost, 28,476 shares and 28,476 shares at December 31, 2016 and March 31, 2017, respectively	(1,376,197)	(1,376,197)
Total Stockholders' Equity	1,131,473	1,099,719
Total Liabilities, Redeemable Non-Controlling Interest and Stockholders' Equity	2,443,061	2,443,687
Ordinary common stock
STOCKHOLDERS' EQUITY
Common stock	522	520
Multi-Vote common stock
STOCKHOLDERS' EQUITY
Common stock